Skip to main content
YS Biopharma Co., Ltd. (YS)
NASDAQ: YS · IEX Real-Time Price · USD
0.725
-0.001 (-0.12%)
At close: May 1, 2024, 10:08 AM
0.740
+0.015 (2.05%)
After-hours: May 1, 2024, 6:12 PM EDT

YS Biopharma Co. Revenue

Revenue in the quarter ending December 31, 2023 was $164.98M, a -9.18% decrease year-over-year. In the fiscal year ending March 31, 2023, YS Biopharma Co. had annual revenue of $687.20M with 36.63% growth.

Revenue (ttm)
$687.20M
Revenue Growth
+36.63%
P/S Ratio
n/a
Revenue / Employee
$889,005
Employees
773
Market Cap
141.25M USD

Revenue Chart

* The company reports in CNY currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 2023687.20M184.25M36.63%
Mar 31, 2022502.95M245.93M95.69%
Mar 31, 2021257.02M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

YS News

More News